Objective markers of silent myocardial ischemia, such as exercise-induced ECG changes and perfusion abnormalities, are associated with adverse outcomes in patients with coronary artery disease.
Answers are grounded in this paper and cite their sources.
May aid CAD risk stratification via silent ischemia markers; leaves open whether intervention improves outcomes.
Reducing morbidity and mortality from coronary artery disease continues to be a major challenge. Many patients with coronary artery disease are asymptomatic or nearly so for long periods, and even when symptoms are present, their severity alone does not predict the outcome. Objective markers associated with an adverse outcome have been identified. They include exercise-induced electrocardiographic (ECG) changes and abnormalities on myocardial-perfusion scans and studies of ventricular wall motion. These abnormalities usually occur in the absence of symptoms but are related to myocardial ischemia — hence, the term “silent ischemia.” It seems more appropriate, however, simply to use the term . . .
No takes yet. Share an insight, caveat, or question.
Carl J. Pepine (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: